These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 411591)

  • 1. [Stimulation of hematopoietic stem cells by antilymphocyte serum].
    Gluckman E; Devergie A; Barrett J; Faille A
    C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(7):841-3. PubMed ID: 411591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human alpha interferon (INF) and antilymphocyte globulin (ALG) on normal and aplastic anaemia haematopoietic progenitor cell growth.
    Zduńczyk A; Miszta H; Dabrowski Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):51-8. PubMed ID: 1695183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin.
    Tichelli A; Gratwohl A; Nissen C; Signer E; Stebler Gysi C; Speck B
    Blood; 1992 Jul; 80(2):337-45. PubMed ID: 1627795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
    Manz CY; Nissen C; Wodnar-Filipowicz A
    Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.
    Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
    Exp Hematol; 1978 Sep; 6(8):679-87. PubMed ID: 361428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Myelophrenia": its contribution to the management of aplastic anemia.
    Nathan DG
    Prog Clin Biol Res; 1984; 148():xxi-xxx. PubMed ID: 6379655
    [No Abstract]   [Full Text] [Related]  

  • 7. [The action of antilymphocyte serum in severe aplastic anemia (author's transl)].
    Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
    Nouv Presse Med; 1978 Feb; 7(6):439-43. PubMed ID: 634781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure].
    Robak T
    Postepy Hig Med Dosw; 1992; 46(1):21-51. PubMed ID: 1641375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphological and pathogenetic aspects of aplastic anemia].
    Abdulkadyrov KM; Bessmel'tsev SS; Balashova VA; Rukavitsyn OA; Shilova ER; Rozanova OE; Bubnova LN
    Morfologiia; 1995; 108(3):58-62. PubMed ID: 8925050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
    Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
    Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current considerations of the etiology of aplastic anemia.
    Gewirtz AM; Hoffman R
    Crit Rev Oncol Hematol; 1985; 4(1):1-30. PubMed ID: 3902262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with aplastic anemia (AA) before or after treatment with anti-thymocyte globulin (ATG) may exhibit clonal hematopoiesis.
    van Kamp H; Landegent JE; Willemze R; Fibbe WE
    Bone Marrow Transplant; 1991; 7 Suppl 2():99. PubMed ID: 1678979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aplastic anemia].
    Klingemann HG; Havemann K
    Dtsch Med Wochenschr; 1984 Nov; 109(47):1816-21. PubMed ID: 6389074
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hematopoietic defect in aplastic anemia assessed by long-term marrow culture.
    Marsh JC; Chang J; Testa NG; Hows JM; Dexter TM
    Blood; 1990 Nov; 76(9):1748-57. PubMed ID: 2224124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aplastic anaemia: Evidence for an immunological mechanism.
    Ascensão J; Pahwa R; Kagan W; Hansen J; Moore M; Good R
    Lancet; 1976 Mar; 1(7961):669-71. PubMed ID: 73642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of severe aplastic anemia].
    Gratwohl A; Osterwalder B; Nissen C; Leibundgut U; Signer E; Lüthy A; Jeannet M; Speck B
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1520-2. PubMed ID: 7031870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive therapy in bone marrow aplasia: the stroma functions normally to support hematopoiesis.
    Novitzky N; Jacobs P
    Exp Hematol; 1995 Dec; 23(14):1472-7. PubMed ID: 8542933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia.
    Chatterjee R; Law S
    Eur J Cell Biol; 2018 Jan; 97(1):32-43. PubMed ID: 29173808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.